tiprankstipranks
Trending News
More News >
OncoTherapy Science, Inc. (DE:30O)
FRANKFURT:30O
Germany Market

OncoTherapy Science (30O) Cash flow

Compare
0 Followers

OncoTherapy Science Cash Flow

DE:30O's free cash flow for Q1 2025 was ¥0.00. For the 2025 fiscal year, DE:30O's free cash flow was decreased by ¥415.32M and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
¥ -815.02M¥ -1.23B¥ -794.90M¥ -2.07B¥ -1.76B
Investing Cash Flow
¥ -279.00K¥ -33.35M¥ -20.32M¥ -467.93M¥ -52.23M
Financing Cash Flow
¥ 1.12B¥ 671.37M¥ 95.95M¥ 1.48B¥ 0.00
End Cash Position
¥ 833.88M¥ 527.66M¥ 1.12B¥ 1.84B¥ 2.90B
Free Cash Flow
¥ -815.30M¥ -1.23B¥ -800.29M¥ -2.53B¥ -1.81B
Currency in JPY

OncoTherapy Science Cash Flow